Evidence map›Paper›PMID 36766608›Full record

ArticleDiagnostics (Basel, Switzerland)2023

How Frequently Benign Uterine Myomas Appear Suspicious for Sarcoma as Assessed by Transvaginal Ultrasound?

Nieves Cabezas, Ana López-Picazo, Patricia Diaz, Beatriz Valero, María José Rodriguez, Ana Redondo, Begoña Díaz-de la Noval, Maria Angela Pascual, Silvia Ajossa, Stefano Guerriero and 1 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nieves CabezasDepartment of Obstetrics and Gynecology, University Hospital Virgen Macarena, 41009 Seville, Spain.
Ana López-PicazoDepartment of Obstetrics and Gynecology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Patricia DiazDepartment Obstetrics and Gynecology, Hospital Fundación Calahorra, 26500 Calahorra, Spain.
Beatriz ValeroDepartment of Obstetrics, Gynecology, and Reproduction, Hospital Universitari Dexeus, 08028 Barcelona, Spain.ORCID 0000-0001-7653-3047
María José RodriguezDepartment of Obstetrics and Gynecology, Central University Hospital Asturias, 33011 Oviedo, Spain.ORCID 0000-0001-6087-9932
Ana RedondoDepartment of Obstetrics and Gynecology, University Hospital Virgen Macarena, 41009 Seville, Spain.
Begoña Díaz-de la NovalDepartment of Obstetrics and Gynecology, Central University Hospital Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-7757-1050
Maria Angela PascualDepartment of Obstetrics, Gynecology, and Reproduction, Hospital Universitari Dexeus, 08028 Barcelona, Spain.ORCID 0000-0001-5095-6981
Silvia AjossaCentro Integrato di Procreazione Medicalmente Assistita (PMA) e Diagnostica Ostetrico-Ginecologica, Azienda Ospedaliero Universitaria-Policlinico Duilio Casula, Monserrato, University of Cagliari, 09042 Cagliari, Italy.
Stefano GuerrieroCentro Integrato di Procreazione Medicalmente Assistita (PMA) e Diagnostica Ostetrico-Ginecologica, Azienda Ospedaliero Universitaria-Policlinico Duilio Casula, Monserrato, University of Cagliari, 09042 Cagliari, Italy.ORCID 0000-0002-1359-7155
Juan Luis AlcázarDepartment of Obstetrics and Gynecology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-9700-0853

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUterine myomas may resemble uterine sarcomas in some cases. However, the rate of benign myomas appearing as sarcomas at an ultrasound examination is not known. The objective of this study is to determine the percentage of benign myomas that appear suspicious for uterine sarcoma on ultrasound examination. This is a prospective observational multicenter study (June 2019-December 2021) comprising a consecutive series of patients with histologically proven uterine myoma after hysterectomy or myomectomy who underwent transvaginal and/or transabdominal ultrasound prior to surgery. All ultrasound examinations were performed by expert examiners. MUSA criteria were used to describe the lesions (1). Suspicion of sarcoma was established when three or more sonographic features, described by Ludovisi et al. as "frequently seen in uterine sarcoma", were present (2). These features are no visible myometrium, irregular cystic areas, non-uniform echogenicity, irregular contour, "cooked" appearance, and a Doppler color score of 3-4. In addition, the examiners had to classify the lesion as suspicious based on her/his impression, independent of the number of features present. Eight hundred and ten women were included. The median maximum diameter of the myomas was 58.7 mm (range: 10.0-263.0 mm). Three hundred and forty-nine (43.1%) of the patients had more than one myoma. Using the criterion of >3 suspicious features, 40 (4.9%) of the myomas had suspicious appearance. By subjective impression, the examiners considered 40 (4.9%) cases suspicious. The cases were not exactly the same. We conclude that approximately 5% of benign uterine myomas may exhibit sonographic suspicion of sarcoma. Although it is a small percentage, it is not negligible.

Indexed as

myomasarcomaultrasounduterus

Identifiers

PMID36766608
PMCPMC9914371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.